Theriva Biologics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Theriva Biologics, Inc. (TOVX) had Deferred Tax Assets, Operating Loss Carryforwards of $13.04 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $13.04M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.71M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.36M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.23M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $13.04M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $9.71M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $27.36M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $22.23M 10-K · filed 2024-03-25 | |
| 2021-12-31 | $16.88M 10-K · filed 2022-03-16 | |
| 2020-12-31 | $12.54M 10-K · filed 2022-03-16 | |
| 2019-12-31 | $8.49M 10-K · filed 2021-03-04 | $48.53M 10-K · filed 2020-02-20 |
| 2018-12-31 | $44.51M 10-K · filed 2020-02-20 | |
| 2017-12-31 | $40.25M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $50.52M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $38.30M 10-K · filed 2017-03-02 | $37.85M 10-K · filed 2016-03-10 |
| 2014-12-31 | $24.66M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $16.17M 10-K · filed 2015-03-16 | |
| 2012-12-31 | $12.06M 10-K · filed 2014-03-31 | $14.96M 10-K · filed 2013-04-16 |
| 2011-12-31 | $10.43M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |